nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Sorafenib—liver cancer	0.201	0.365	CbGbCtD
Sitagliptin—ABCB1—Sorafenib—liver cancer	0.136	0.247	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—liver cancer	0.0827	0.15	CbGbCtD
Sitagliptin—CYP3A4—Sorafenib—liver cancer	0.0817	0.148	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—liver cancer	0.0496	0.0899	CbGbCtD
Sitagliptin—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.00635	0.0178	CcSEcCtD
Sitagliptin—Fungal skin infection—Epirubicin—liver cancer	0.00507	0.0142	CcSEcCtD
Sitagliptin—Fungal skin infection—Doxorubicin—liver cancer	0.00469	0.0131	CcSEcCtD
Sitagliptin—Eczema—Sorafenib—liver cancer	0.00463	0.013	CcSEcCtD
Sitagliptin—Renal failure acute—Sorafenib—liver cancer	0.00451	0.0126	CcSEcCtD
Sitagliptin—Bundle branch block—Epirubicin—liver cancer	0.0042	0.0118	CcSEcCtD
Sitagliptin—Pain in extremity—Sorafenib—liver cancer	0.00416	0.0116	CcSEcCtD
Sitagliptin—Bundle branch block—Doxorubicin—liver cancer	0.00388	0.0109	CcSEcCtD
Sitagliptin—Abdominal pain upper—Sorafenib—liver cancer	0.0038	0.0106	CcSEcCtD
Sitagliptin—Breast disorder—Sorafenib—liver cancer	0.00376	0.0105	CcSEcCtD
Sitagliptin—Nasopharyngitis—Sorafenib—liver cancer	0.00372	0.0104	CcSEcCtD
Sitagliptin—Pancreatitis—Sorafenib—liver cancer	0.00353	0.00987	CcSEcCtD
Sitagliptin—Abdominal discomfort—Sorafenib—liver cancer	0.00345	0.00965	CcSEcCtD
Sitagliptin—Serum creatinine increased—Epirubicin—liver cancer	0.00344	0.00964	CcSEcCtD
Sitagliptin—Erectile dysfunction—Sorafenib—liver cancer	0.00331	0.00927	CcSEcCtD
Sitagliptin—Parosmia—Epirubicin—liver cancer	0.00327	0.00914	CcSEcCtD
Sitagliptin—Pneumonia—Sorafenib—liver cancer	0.00322	0.00903	CcSEcCtD
Sitagliptin—Infestation—Sorafenib—liver cancer	0.00321	0.00898	CcSEcCtD
Sitagliptin—Infestation NOS—Sorafenib—liver cancer	0.00321	0.00898	CcSEcCtD
Sitagliptin—Serum creatinine increased—Doxorubicin—liver cancer	0.00319	0.00892	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00318	0.0089	CcSEcCtD
Sitagliptin—Renal failure—Sorafenib—liver cancer	0.00315	0.00882	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Sorafenib—liver cancer	0.00314	0.0088	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Sorafenib—liver cancer	0.00303	0.00849	CcSEcCtD
Sitagliptin—Parosmia—Doxorubicin—liver cancer	0.00302	0.00846	CcSEcCtD
Sitagliptin—Lung disorder—Epirubicin—liver cancer	0.00299	0.00838	CcSEcCtD
Sitagliptin—Urinary tract disorder—Sorafenib—liver cancer	0.00284	0.00796	CcSEcCtD
Sitagliptin—Connective tissue disorder—Sorafenib—liver cancer	0.00283	0.00792	CcSEcCtD
Sitagliptin—Urethral disorder—Sorafenib—liver cancer	0.00282	0.0079	CcSEcCtD
Sitagliptin—Herpes zoster—Epirubicin—liver cancer	0.00281	0.00788	CcSEcCtD
Sitagliptin—Lung disorder—Doxorubicin—liver cancer	0.00277	0.00775	CcSEcCtD
Sitagliptin—Erythema multiforme—Sorafenib—liver cancer	0.00272	0.00762	CcSEcCtD
Sitagliptin—Cardiac disorder—Sorafenib—liver cancer	0.00267	0.00748	CcSEcCtD
Sitagliptin—Angiopathy—Sorafenib—liver cancer	0.00261	0.00731	CcSEcCtD
Sitagliptin—Herpes zoster—Doxorubicin—liver cancer	0.0026	0.00729	CcSEcCtD
Sitagliptin—Immune system disorder—Sorafenib—liver cancer	0.0026	0.00728	CcSEcCtD
Sitagliptin—Mediastinal disorder—Sorafenib—liver cancer	0.00259	0.00726	CcSEcCtD
Sitagliptin—Mental disorder—Sorafenib—liver cancer	0.00252	0.00706	CcSEcCtD
Sitagliptin—Malnutrition—Sorafenib—liver cancer	0.00251	0.00701	CcSEcCtD
Sitagliptin—Muscle spasms—Sorafenib—liver cancer	0.00241	0.00674	CcSEcCtD
Sitagliptin—Cellulitis—Epirubicin—liver cancer	0.00233	0.00652	CcSEcCtD
Sitagliptin—Angioedema—Sorafenib—liver cancer	0.00229	0.00641	CcSEcCtD
Sitagliptin—Cough—Sorafenib—liver cancer	0.00219	0.00612	CcSEcCtD
Sitagliptin—Hypertension—Sorafenib—liver cancer	0.00216	0.00606	CcSEcCtD
Sitagliptin—Cellulitis—Doxorubicin—liver cancer	0.00216	0.00603	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Epirubicin—liver cancer	0.00214	0.006	CcSEcCtD
Sitagliptin—Neck pain—Epirubicin—liver cancer	0.00214	0.006	CcSEcCtD
Sitagliptin—Myalgia—Sorafenib—liver cancer	0.00213	0.00597	CcSEcCtD
Sitagliptin—Arthralgia—Sorafenib—liver cancer	0.00213	0.00597	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00212	0.00593	CcSEcCtD
Sitagliptin—Dry mouth—Sorafenib—liver cancer	0.00209	0.00584	CcSEcCtD
Sitagliptin—Anaphylactic shock—Sorafenib—liver cancer	0.00204	0.00572	CcSEcCtD
Sitagliptin—Infection—Sorafenib—liver cancer	0.00203	0.00569	CcSEcCtD
Sitagliptin—Nervous system disorder—Sorafenib—liver cancer	0.00201	0.00561	CcSEcCtD
Sitagliptin—Skin disorder—Sorafenib—liver cancer	0.00199	0.00556	CcSEcCtD
Sitagliptin—Neck pain—Doxorubicin—liver cancer	0.00198	0.00555	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Doxorubicin—liver cancer	0.00198	0.00555	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00186	0.00522	CcSEcCtD
Sitagliptin—Dyspepsia—Sorafenib—liver cancer	0.0018	0.00504	CcSEcCtD
Sitagliptin—Decreased appetite—Sorafenib—liver cancer	0.00178	0.00498	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00177	0.00494	CcSEcCtD
Sitagliptin—Fatigue—Sorafenib—liver cancer	0.00176	0.00494	CcSEcCtD
Sitagliptin—Constipation—Sorafenib—liver cancer	0.00175	0.0049	CcSEcCtD
Sitagliptin—Pain—Sorafenib—liver cancer	0.00175	0.0049	CcSEcCtD
Sitagliptin—Eczema—Epirubicin—liver cancer	0.00171	0.00479	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Sorafenib—liver cancer	0.00167	0.00468	CcSEcCtD
Sitagliptin—Renal failure acute—Epirubicin—liver cancer	0.00167	0.00466	CcSEcCtD
Sitagliptin—Urticaria—Sorafenib—liver cancer	0.00162	0.00455	CcSEcCtD
Sitagliptin—Abdominal pain—Sorafenib—liver cancer	0.00162	0.00453	CcSEcCtD
Sitagliptin—Renal impairment—Epirubicin—liver cancer	0.00162	0.00452	CcSEcCtD
Sitagliptin—Eczema—Doxorubicin—liver cancer	0.00158	0.00443	CcSEcCtD
Sitagliptin—Hypoglycaemia—Epirubicin—liver cancer	0.00158	0.00441	CcSEcCtD
Sitagliptin—Renal failure acute—Doxorubicin—liver cancer	0.00154	0.00431	CcSEcCtD
Sitagliptin—Pain in extremity—Epirubicin—liver cancer	0.00154	0.0043	CcSEcCtD
Sitagliptin—Osteoarthritis—Epirubicin—liver cancer	0.00154	0.0043	CcSEcCtD
Sitagliptin—Migraine—Epirubicin—liver cancer	0.00151	0.00424	CcSEcCtD
Sitagliptin—Hypersensitivity—Sorafenib—liver cancer	0.00151	0.00422	CcSEcCtD
Sitagliptin—Renal impairment—Doxorubicin—liver cancer	0.00149	0.00419	CcSEcCtD
Sitagliptin—Face oedema—Epirubicin—liver cancer	0.00148	0.00416	CcSEcCtD
Sitagliptin—Asthenia—Sorafenib—liver cancer	0.00147	0.00411	CcSEcCtD
Sitagliptin—Hypoglycaemia—Doxorubicin—liver cancer	0.00146	0.00408	CcSEcCtD
Sitagliptin—Blood creatinine increased—Epirubicin—liver cancer	0.00144	0.00403	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—liver cancer	0.00142	0.00398	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—liver cancer	0.00142	0.00398	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Epirubicin—liver cancer	0.0014	0.00393	CcSEcCtD
Sitagliptin—Abdominal pain upper—Epirubicin—liver cancer	0.0014	0.00393	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—liver cancer	0.0014	0.00392	CcSEcCtD
Sitagliptin—Diarrhoea—Sorafenib—liver cancer	0.0014	0.00392	CcSEcCtD
Sitagliptin—Breast disorder—Epirubicin—liver cancer	0.00139	0.00389	CcSEcCtD
Sitagliptin—Nasopharyngitis—Epirubicin—liver cancer	0.00138	0.00385	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—liver cancer	0.00137	0.00385	CcSEcCtD
Sitagliptin—Dizziness—Sorafenib—liver cancer	0.00135	0.00379	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—liver cancer	0.00133	0.00373	CcSEcCtD
Sitagliptin—Influenza—Epirubicin—liver cancer	0.00133	0.00372	CcSEcCtD
Sitagliptin—Pancreatitis—Epirubicin—liver cancer	0.0013	0.00365	CcSEcCtD
Sitagliptin—Vomiting—Sorafenib—liver cancer	0.0013	0.00364	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—liver cancer	0.0013	0.00364	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—liver cancer	0.0013	0.00364	CcSEcCtD
Sitagliptin—Rash—Sorafenib—liver cancer	0.00129	0.00361	CcSEcCtD
Sitagliptin—Dermatitis—Sorafenib—liver cancer	0.00129	0.00361	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—liver cancer	0.00129	0.0036	CcSEcCtD
Sitagliptin—Headache—Sorafenib—liver cancer	0.00128	0.00359	CcSEcCtD
Sitagliptin—Bronchitis—Epirubicin—liver cancer	0.00128	0.00358	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—liver cancer	0.00127	0.00356	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Epirubicin—liver cancer	0.00124	0.00346	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—liver cancer	0.00123	0.00344	CcSEcCtD
Sitagliptin—Nausea—Sorafenib—liver cancer	0.00121	0.0034	CcSEcCtD
Sitagliptin—Weight increased—Epirubicin—liver cancer	0.00121	0.00339	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—liver cancer	0.00121	0.00338	CcSEcCtD
Sitagliptin—Hyperglycaemia—Epirubicin—liver cancer	0.0012	0.00336	CcSEcCtD
Sitagliptin—Pneumonia—Epirubicin—liver cancer	0.00119	0.00334	CcSEcCtD
Sitagliptin—Infestation—Epirubicin—liver cancer	0.00118	0.00332	CcSEcCtD
Sitagliptin—Infestation NOS—Epirubicin—liver cancer	0.00118	0.00332	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—liver cancer	0.00118	0.00331	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00117	0.00329	CcSEcCtD
Sitagliptin—Renal failure—Epirubicin—liver cancer	0.00116	0.00326	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Epirubicin—liver cancer	0.00116	0.00325	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—liver cancer	0.00115	0.00322	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00114	0.0032	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—liver cancer	0.00112	0.00314	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—liver cancer	0.00112	0.00313	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—liver cancer	0.00111	0.00311	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—liver cancer	0.00111	0.00311	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—liver cancer	0.0011	0.00309	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—liver cancer	0.0011	0.00307	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—liver cancer	0.0011	0.00307	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00109	0.00304	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—liver cancer	0.00108	0.00302	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—liver cancer	0.00107	0.00301	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—liver cancer	0.00107	0.00298	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—liver cancer	0.00106	0.00296	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—liver cancer	0.00106	0.00296	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—liver cancer	0.00105	0.00294	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—liver cancer	0.00105	0.00293	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—liver cancer	0.00105	0.00293	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—liver cancer	0.00104	0.00292	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—liver cancer	0.00104	0.0029	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—liver cancer	0.00103	0.00288	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—liver cancer	0.00101	0.00282	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—liver cancer	0.000994	0.00278	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—liver cancer	0.000987	0.00276	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—liver cancer	0.000979	0.00274	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—liver cancer	0.000977	0.00273	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—liver cancer	0.000972	0.00272	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—liver cancer	0.00097	0.00271	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—liver cancer	0.000967	0.00271	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—liver cancer	0.000965	0.0027	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—liver cancer	0.000965	0.0027	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—liver cancer	0.000961	0.00269	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—liver cancer	0.000959	0.00268	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—liver cancer	0.000932	0.00261	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—liver cancer	0.000931	0.00261	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—liver cancer	0.000926	0.00259	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—liver cancer	0.00092	0.00258	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—liver cancer	0.000913	0.00256	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—liver cancer	0.000912	0.00255	CcSEcCtD
Sitagliptin—Tension—Epirubicin—liver cancer	0.000909	0.00254	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—liver cancer	0.000899	0.00252	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—liver cancer	0.000896	0.00251	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—liver cancer	0.000893	0.0025	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—liver cancer	0.00089	0.00249	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—liver cancer	0.000889	0.00249	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—liver cancer	0.000887	0.00248	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—liver cancer	0.000873	0.00244	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—liver cancer	0.000862	0.00241	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—liver cancer	0.000859	0.00241	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—liver cancer	0.000857	0.0024	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—liver cancer	0.000844	0.00236	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—liver cancer	0.000841	0.00235	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—liver cancer	0.000835	0.00234	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—liver cancer	0.000832	0.00233	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—liver cancer	0.000832	0.00233	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—liver cancer	0.000829	0.00232	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—liver cancer	0.000824	0.00231	CcSEcCtD
Sitagliptin—Cough—Epirubicin—liver cancer	0.000808	0.00226	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—liver cancer	0.000807	0.00226	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—liver cancer	0.000799	0.00224	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—liver cancer	0.000795	0.00223	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—liver cancer	0.000788	0.00221	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—liver cancer	0.000788	0.00221	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—liver cancer	0.000786	0.0022	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000783	0.00219	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—liver cancer	0.000779	0.00218	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—liver cancer	0.000773	0.00216	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—liver cancer	0.000771	0.00216	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—liver cancer	0.00077	0.00216	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—liver cancer	0.000756	0.00212	CcSEcCtD
Sitagliptin—Infection—Epirubicin—liver cancer	0.000751	0.0021	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—liver cancer	0.000748	0.00209	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—HPGDS—liver cancer	0.000746	0.00817	CbGpPWpGaD
Sitagliptin—Nervous system disorder—Epirubicin—liver cancer	0.000741	0.00207	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—liver cancer	0.00074	0.00207	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—liver cancer	0.000734	0.00206	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—liver cancer	0.000729	0.00204	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—liver cancer	0.000729	0.00204	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—liver cancer	0.000727	0.00204	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000724	0.00203	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000721	0.0079	CbGpPWpGaD
Sitagliptin—Discomfort—Doxorubicin—liver cancer	0.000721	0.00202	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—liver cancer	0.000713	0.002	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—UGDH—liver cancer	0.000711	0.00779	CbGpPWpGaD
Sitagliptin—Anaphylactic shock—Doxorubicin—liver cancer	0.000699	0.00196	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—liver cancer	0.000695	0.00194	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000689	0.00193	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—liver cancer	0.000686	0.00192	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—liver cancer	0.000684	0.00191	CcSEcCtD
Sitagliptin—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00068	0.00744	CbGpPWpGaD
Sitagliptin—Skin disorder—Doxorubicin—liver cancer	0.000679	0.0019	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—liver cancer	0.000672	0.00188	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—liver cancer	0.000665	0.00186	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—liver cancer	0.000657	0.00184	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000654	0.00716	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000652	0.00183	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—liver cancer	0.000652	0.00182	CcSEcCtD
Sitagliptin—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00065	0.00712	CbGpPWpGaD
Sitagliptin—Constipation—Epirubicin—liver cancer	0.000646	0.00181	CcSEcCtD
Sitagliptin—Pain—Epirubicin—liver cancer	0.000646	0.00181	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000637	0.00178	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—liver cancer	0.000632	0.00177	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—liver cancer	0.000623	0.00174	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—liver cancer	0.000622	0.00174	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—liver cancer	0.000618	0.00173	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—liver cancer	0.000616	0.00172	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—liver cancer	0.000608	0.0017	CcSEcCtD
Sitagliptin—ABCB1—Allograft Rejection—IL12A—liver cancer	0.000607	0.00664	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000604	0.00169	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—liver cancer	0.000603	0.00169	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—liver cancer	0.0006	0.00168	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—liver cancer	0.000598	0.00167	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—liver cancer	0.000598	0.00167	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—liver cancer	0.000597	0.00167	CcSEcCtD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000584	0.00639	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Doxorubicin—liver cancer	0.000576	0.00161	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000572	0.0016	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00056	0.00614	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—GGT1—liver cancer	0.000558	0.00612	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Epirubicin—liver cancer	0.000557	0.00156	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—liver cancer	0.000556	0.00156	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—liver cancer	0.000553	0.00155	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—liver cancer	0.000542	0.00152	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000531	0.00582	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.000531	0.00581	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000526	0.00576	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000519	0.00568	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000518	0.00567	CbGpPWpGaD
Sitagliptin—Diarrhoea—Epirubicin—liver cancer	0.000517	0.00145	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—liver cancer	0.000515	0.00144	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—ATF3—liver cancer	0.000509	0.00557	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000509	0.00557	CbGpPWpGaD
Sitagliptin—Asthenia—Doxorubicin—liver cancer	0.000502	0.0014	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—liver cancer	0.0005	0.0014	CcSEcCtD
Sitagliptin—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000488	0.00535	CbGpPWpGaD
Sitagliptin—Vomiting—Epirubicin—liver cancer	0.000481	0.00135	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—liver cancer	0.000478	0.00134	CcSEcCtD
Sitagliptin—Rash—Epirubicin—liver cancer	0.000477	0.00133	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—liver cancer	0.000476	0.00133	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000474	0.00519	CbGpPWpGaD
Sitagliptin—Headache—Epirubicin—liver cancer	0.000473	0.00133	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00047	0.00514	CbGpPWpGaD
Sitagliptin—Dizziness—Doxorubicin—liver cancer	0.000462	0.00129	CcSEcCtD
Sitagliptin—Nausea—Epirubicin—liver cancer	0.000449	0.00126	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—liver cancer	0.000445	0.00124	CcSEcCtD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000444	0.00487	CbGpPWpGaD
Sitagliptin—Rash—Doxorubicin—liver cancer	0.000441	0.00123	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—liver cancer	0.000441	0.00123	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—liver cancer	0.000438	0.00123	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000437	0.00479	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.000434	0.00475	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000426	0.00467	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00042	0.0046	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—NR1H4—liver cancer	0.000416	0.00455	CbGpPWpGaD
Sitagliptin—Nausea—Doxorubicin—liver cancer	0.000415	0.00116	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—GSTA3—liver cancer	0.000409	0.00447	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTA3—liver cancer	0.000403	0.00441	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000392	0.00429	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000382	0.00418	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL12B—liver cancer	0.000381	0.00417	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000378	0.00414	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTA4—liver cancer	0.000374	0.00409	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000373	0.00408	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTA4—liver cancer	0.000369	0.00404	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTA2—liver cancer	0.000364	0.00399	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTA1—liver cancer	0.000351	0.00385	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000349	0.00382	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—NAT2—liver cancer	0.000347	0.0038	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.000345	0.00378	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—NAT2—liver cancer	0.000343	0.00375	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—IGF2—liver cancer	0.000315	0.00345	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000306	0.00335	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000299	0.00327	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000299	0.00327	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000292	0.0032	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000292	0.00319	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GPX3—liver cancer	0.000291	0.00319	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000283	0.0031	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000282	0.00309	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000278	0.00305	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—HPGDS—liver cancer	0.000278	0.00304	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000257	0.00281	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000251	0.00275	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000241	0.00264	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—F2—liver cancer	0.000231	0.00253	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000229	0.00251	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000227	0.00248	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP2E1—liver cancer	0.000226	0.00248	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP2E1—liver cancer	0.000223	0.00245	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000223	0.00244	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000222	0.00244	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000219	0.0024	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000218	0.00239	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000216	0.00237	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GGT1—liver cancer	0.000208	0.00228	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000208	0.00227	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000203	0.00222	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000201	0.0022	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.0002	0.00219	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000198	0.00217	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MMP2—liver cancer	0.000196	0.00215	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000195	0.00214	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000189	0.00206	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTP1—liver cancer	0.000187	0.00204	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000186	0.00204	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTP1—liver cancer	0.000184	0.00202	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000184	0.00201	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTM1—liver cancer	0.000172	0.00188	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTM1—liver cancer	0.000169	0.00185	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000167	0.00183	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000165	0.00181	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000164	0.0018	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000163	0.00179	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1A1—liver cancer	0.000163	0.00178	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1A1—liver cancer	0.00016	0.00176	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00016	0.00175	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000156	0.00171	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000153	0.00167	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTNNB1—liver cancer	0.00015	0.00165	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000149	0.00163	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000146	0.0016	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000146	0.0016	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000146	0.0016	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL2—liver cancer	0.000146	0.00159	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000143	0.00156	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00014	0.00153	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00014	0.00153	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000132	0.00145	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000125	0.00137	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000124	0.00135	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000122	0.00134	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—UGDH—liver cancer	0.000122	0.00133	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000122	0.00133	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.00012	0.00131	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—EPT1—liver cancer	0.000114	0.00125	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000114	0.00124	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000112	0.00122	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00011	0.00121	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TAT—liver cancer	0.000108	0.00119	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000108	0.00118	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000107	0.00117	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—liver cancer	0.000106	0.00116	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—UGDH—liver cancer	0.000106	0.00116	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000102	0.00112	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.0001	0.0011	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—EPT1—liver cancer	9.96e-05	0.00109	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	9.88e-05	0.00108	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TAT—liver cancer	9.45e-05	0.00103	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.21e-05	0.00101	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	9.11e-05	0.000998	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	9.08e-05	0.000995	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	8.73e-05	0.000956	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	8.61e-05	0.000943	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	8.01e-05	0.000877	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	7.98e-05	0.000874	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CPT1B—liver cancer	7.37e-05	0.000807	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GLUL—liver cancer	7.37e-05	0.000807	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	7.34e-05	0.000804	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	7.19e-05	0.000788	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NR1H4—liver cancer	7.11e-05	0.000778	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	7e-05	0.000767	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	6.99e-05	0.000765	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA3—liver cancer	6.99e-05	0.000765	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	6.93e-05	0.000759	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	6.77e-05	0.000742	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	6.74e-05	0.000738	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	6.61e-05	0.000724	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—UGDH—liver cancer	6.53e-05	0.000715	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CPT1B—liver cancer	6.42e-05	0.000703	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GLUL—liver cancer	6.42e-05	0.000703	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA4—liver cancer	6.39e-05	0.0007	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.25e-05	0.000684	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA2—liver cancer	6.23e-05	0.000682	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NR1H4—liver cancer	6.19e-05	0.000678	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—EPT1—liver cancer	6.14e-05	0.000672	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	6.1e-05	0.000668	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA3—liver cancer	6.09e-05	0.000667	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA1—liver cancer	6.01e-05	0.000658	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NAT2—liver cancer	5.94e-05	0.000651	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.86e-05	0.000641	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TAT—liver cancer	5.82e-05	0.000637	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.71e-05	0.000626	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDOB—liver cancer	5.7e-05	0.000624	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.62e-05	0.000615	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.6e-05	0.000614	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA4—liver cancer	5.57e-05	0.00061	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CRABP1—liver cancer	5.43e-05	0.000595	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA2—liver cancer	5.43e-05	0.000594	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA1—liver cancer	5.23e-05	0.000573	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.23e-05	0.000573	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.19e-05	0.000568	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NAT2—liver cancer	5.18e-05	0.000567	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDOB—liver cancer	4.96e-05	0.000543	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.89e-05	0.000536	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.77e-05	0.000522	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HPGDS—liver cancer	4.75e-05	0.00052	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CRABP1—liver cancer	4.73e-05	0.000518	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	4.73e-05	0.000518	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.72e-05	0.000517	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.61e-05	0.000505	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.3e-05	0.000471	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.25e-05	0.000465	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSMD10—liver cancer	4.23e-05	0.000464	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSMA4—liver cancer	4.23e-05	0.000464	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HPGDS—liver cancer	4.14e-05	0.000453	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GOT2—liver cancer	4.12e-05	0.000451	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CPT1B—liver cancer	3.96e-05	0.000433	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GLUL—liver cancer	3.96e-05	0.000433	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.89e-05	0.000426	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2E1—liver cancer	3.87e-05	0.000424	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NR1H4—liver cancer	3.81e-05	0.000418	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA3—liver cancer	3.75e-05	0.000411	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.75e-05	0.00041	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSMA4—liver cancer	3.69e-05	0.000404	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSMD10—liver cancer	3.69e-05	0.000404	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYCS—liver cancer	3.62e-05	0.000397	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GOT2—liver cancer	3.59e-05	0.000393	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GOT1—liver cancer	3.55e-05	0.000389	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GGT1—liver cancer	3.55e-05	0.000389	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.52e-05	0.000385	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA4—liver cancer	3.43e-05	0.000376	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2E1—liver cancer	3.37e-05	0.000369	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA2—liver cancer	3.34e-05	0.000366	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA1—liver cancer	3.22e-05	0.000353	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—liver cancer	3.19e-05	0.00035	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NAT2—liver cancer	3.19e-05	0.000349	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.18e-05	0.000348	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYCS—liver cancer	3.16e-05	0.000346	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMOX1—liver cancer	3.15e-05	0.000345	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GOT1—liver cancer	3.1e-05	0.000339	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GGT1—liver cancer	3.1e-05	0.000339	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDOB—liver cancer	3.06e-05	0.000335	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—liver cancer	2.93e-05	0.000321	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CRABP1—liver cancer	2.92e-05	0.000319	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—liver cancer	2.78e-05	0.000305	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A1—liver cancer	2.78e-05	0.000305	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMOX1—liver cancer	2.74e-05	0.0003	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTHFR—liver cancer	2.59e-05	0.000284	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—liver cancer	2.56e-05	0.00028	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HPGDS—liver cancer	2.55e-05	0.000279	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARA—liver cancer	2.54e-05	0.000279	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A1—liver cancer	2.42e-05	0.000265	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.29e-05	0.00025	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSMD10—liver cancer	2.27e-05	0.000249	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSMA4—liver cancer	2.27e-05	0.000249	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTHFR—liver cancer	2.26e-05	0.000247	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARA—liver cancer	2.22e-05	0.000243	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GOT2—liver cancer	2.21e-05	0.000242	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—liver cancer	2.18e-05	0.000239	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—liver cancer	2.1e-05	0.00023	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2E1—liver cancer	2.08e-05	0.000228	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYCS—liver cancer	1.94e-05	0.000213	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CD—liver cancer	1.92e-05	0.00021	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GGT1—liver cancer	1.91e-05	0.000209	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GOT1—liver cancer	1.91e-05	0.000209	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—liver cancer	1.9e-05	0.000208	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALB—liver cancer	1.89e-05	0.000207	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—liver cancer	1.83e-05	0.000201	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—liver cancer	1.71e-05	0.000188	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMOX1—liver cancer	1.69e-05	0.000185	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CB—liver cancer	1.67e-05	0.000183	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CD—liver cancer	1.67e-05	0.000183	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALB—liver cancer	1.65e-05	0.00018	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—liver cancer	1.57e-05	0.000172	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A1—liver cancer	1.49e-05	0.000163	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CB—liver cancer	1.45e-05	0.000159	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTHFR—liver cancer	1.39e-05	0.000152	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARA—liver cancer	1.37e-05	0.00015	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—liver cancer	1.17e-05	0.000128	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—liver cancer	1.13e-05	0.000124	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CD—liver cancer	1.03e-05	0.000113	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—liver cancer	1.02e-05	0.000111	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALB—liver cancer	1.01e-05	0.000111	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CB—liver cancer	8.96e-06	9.81e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—liver cancer	8.87e-06	9.71e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—liver cancer	8.31e-06	9.1e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—liver cancer	7.24e-06	7.93e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—liver cancer	5.46e-06	5.98e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—liver cancer	4.46e-06	4.89e-05	CbGpPWpGaD
